title: Adenosine A2A receptor antagonism and genetic deletion attenuate the effects of dopamine D2 antagonism on effort-based decision making in mice.
abstract: Brain dopamine (DA) and adenosine interact in the regulation of behavioral activation and effort-related processes. In the present studies, a T-maze task was developed in mice for the assessment of effort-related decision making. With this task, the two arms of the maze have different reinforcement densities, and a vertical barrier is positioned in the arm with the higher density (HD), presenting the animal with an effort-related challenge. Under control conditions mice prefer the HD arm, and climb the barrier to obtain the larger amount of food. The DA D(2) receptor antagonist haloperidol decreased selection of the HD arm and increased selection of the arm with the low density of reinforcement. However, the HD arm was still the preferred choice in haloperidol-treated mice trained with barriers in both arms. Pre-feeding the mice to reduce food motivation dramatically increased omissions, an effect that was distinct from the actions of haloperidol. Co-administration of theophylline, a nonselective adenosine receptor antagonist, partially reversed the effects of haloperidol. This effect seems to be mediated by the A(2A) receptor but not the A(1) receptor, since the A(2A) antagonist MSX-3, but not the A(1) antagonist CPT, dose dependently reversed the effects of haloperidol on effort-related choice and on c-Fos expression in the dorsal striatum and nucleus accumbens. In addition, adenosine A(2A) receptor knockout mice were resistant to the effects of haloperidol on effort-related choice in the maze. These results indicate that DA D(2) and adenosine A(2A) receptors interact to regulate effort-related decision making and effort expenditure in mice.
authors.affiliation: Àrea de Psicobiologia, Campus de Riu Sec, Universitat Jaume I, 12071 Castelló, Spain. mpardo@psb.uji.es
authors.forename: M
authors.initials: M
authors.lastname: Pardo
authors.forename: L
authors.initials: L
authors.lastname: Lopez-Cruz
authors.forename: O
authors.initials: O
authors.lastname: Valverde
authors.forename: C
authors.initials: C
authors.lastname: Ledent
authors.forename: Y
authors.initials: Y
authors.lastname: Baqi
authors.forename: C E
authors.initials: CE
authors.lastname: Müller
authors.forename: J D
authors.initials: JD
authors.lastname: Salamone
authors.forename: M
authors.initials: M
authors.lastname: Correa
mesh_terms: D058917:Adenosine A2 Receptor Antagonists / Q000494:pharmacology*; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects / Q000502:physiology; D003657:Decision Making / Q000187:drug effects* / Q000502:physiology; D018492:Dopamine Antagonists / Q000494:pharmacology*; D065127:Dopamine D2 Receptor Antagonists; D006220:Haloperidol / Q000494:pharmacology; D051379:Mice; D018345:Mice, Knockout; D009042:Motivation / Q000187:drug effects / Q000502:physiology; D043705:Receptor, Adenosine A2A / Q000235:genetics / Q000378:metabolism*; D012054:Reinforcement, Psychology
chemical_list: D058917:Adenosine A2 Receptor Antagonists; D018492:Dopamine Antagonists; D065127:Dopamine D2 Receptor Antagonists; D043705:Receptor, Adenosine A2A; D006220:Haloperidol